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Background. In the pathophysiology of implant failure, metal ions and inflammation-driven osteoclasts (OC) play a crucial role.
The aim of this study was to investigate whether vanadium (V) ions induce differentiation of monocytic OC precursors into
osteoresorptive multinucleated cells. In addition, the influence of V ions on the activation and function of in vitro generated
OC was observed. Methods. Human monocytes and osteoclasts were isolated from peripheral blood monocytic cells (PBMCs).
Exposition with increasing concentrations (0–3𝜇M) of V4+/V5+ ions for 7 days followed. Assessment of OC differentiation,
cell viability, and resorptional ability was performed by standard colorimetric cell viability assay 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenil)-2H-tetrazolium (MTS), tartrate-resistant acid phosphatase (TRAP) expression, and
functional resorption assays on bone slides during a period of 21 days. Results. No significant differences were noted between
V4+/V5+ ions (𝑝 > 0.05). MTS showed significant reduction in cellular viability by V concentrations above 3 𝜇M (𝑝 < 0.05). V
concentrations above 0.5𝜇M showed negative effects on OC activation/differentiation. Higher V concentrations showed negative
effects on resorptive function (all𝑝 < 0.05) without affecting cell viability. V4+/V5+ concentrations below 3𝜇Mhave negative effects
on OC differentiation/function without affecting cell survival. Conclusion. Vanadium-containing implants may reduce implant
failure rate by influencing osteoclast activity at the bone-implant interface. V-ligand complexes might offer new treatment options
by accumulating in the bone.
1. Introduction
Metal-based implants have become essential and very suc-
cessful treatment tools in dental and orthopedic trauma
surgery. Implant failure rates are usually well below 5% for
the first two years. The rates may increase up to 10–20%
under local inflammatory conditions, including periodontitis
and allergic reactions against the metal implant [1]. To date,
surgical revision is the gold standard in treating implant
failure. With an increasingly ageing population, implant
failure with the consequent need of revision surgery will have
a clinical and economic significance in the future.
Aseptic loosening (AL) is the leading cause of failure of
total joint arthroplasty [2]. Aside from the well investigated
and recognized role of wear debris (in the nanometer range)
in the initiation and development of AL, over the last years,
there has been increasing evidence that involvement of
metal ions released by biocorrosion might influence AL by
enhancing osteolysis and decreasing osseointegration [3, 4].
Various metal alloys used in metal implants contain
vanadium (V), which gives the alloy favorable physico-
chemical and mechanical properties. Several in vitro and
in vivo studies have investigated the bioactivity of V and
different V compounds. It has been demonstrated that V
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compounds have an insulin and growth factor mimicking
action [5, 6]. In addition, V compounds largely influence
phosphatases, a group of enzymes mainly associated with
the cell membrane [7]. Phosphatases, specifically the tartrate-
resistant acid phosphatase (TRAP), play a paramount role
in osteoclastic activities. Inhibiting TRAP might reduce the
risk of AL. In vivo studies carried out to investigate the
biodistribution of V compounds showed that V accumulates
predominantly in the bone, kidney, spleen, and liver after 24 h
of administration [8]. A recently published study has also
shown that V compounds are able to regulate osteoblastic
growth [9]. In particular, V ions released by biocorrosion
frommetal implants and accumulated in the bone could exert
specific effects on bone turnover and more specifically on
OC. Little is known about the potential biological effects of V
ions on OC. In this study, we investigate the hypothesis that
V4+ and V5+ ions may interfere with OC differentiation and
activation using a well-established in vitro humanOCmodel,
as well as an in vitro bone resorption model.
2. Methods
2.1. Isolation of Peripheral Blood Monocytic Cells and Gen-
eration of Osteoclasts. The study protocol established by
Lionetto et al. was used in the experiments [10]. Ficoll-
gradient centrifugation (Amersham Biosciences, Uppsala,
Sweden) was used to isolate pooled peripheral blood mono-
cytic cells (PBMCs) from buffy coats of healthy blood
donors. RPMI-1640 plus GlutaMAX medium (RPMI)
(Gibco/Invitrogen, Auckland, New Zealand) supplemented
with 5% human serum and 1% antibiotics (10,000 units/mL
penicillin G sodium, 10,000 𝜇g/mL streptomycin sulfate, and
25 𝜇g/mL amphotericin B (Gibco standard medium)) was
the culture medium for PBMCs at 37∘C (humified, 5% CO
2
,
in 25 cm2 tissue culture flasks (Sarstedt)). The nonadherent
PBMCs were discarded and the adherent PBMCs were
washed twice using 0.1M phosphate-buffered saline (PBS,
pH = 7.2), scraped off, and resuspended in standard medium
after 1 h of culturing.These cells were used as monocytic cells
(MCs) as described below.
To generate theOC, cell cultures of adherent PBMCswere
supplemented with OC differentiation cytokines (10 ng/mL
recombinant human macrophage-colony stimulating factor
(hM-CSF) and 10 ng/mL recombinant human receptor acti-
vator of NF-𝜅B ligand (hRANKL) (ReproTech, Rocky Hill,
NJ, USA)).
2.2. Cell Culture Conditions. The MC, MC supplemented
with OC differentiation cytokines, and mature OC were
subsequently exposed to increasing concentrations (0 to
3 𝜇M) of bis(maltolato)oxovanadium(IV) (BMOV) V4+
or oxidized bis(maltolato)oxovanadium(V) (oxBMOV)
V5+ ions for 7 days. Cell viability was assessed using
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium (MTS) colorimetric assay
(Promega, Madison, WI, USA). The assays were repeated
four times for each experimental condition, and the mean
optical light density was recorded using a microplate reader
(Labsystems, Helsinki, Finland) at an absorbance of 492 nm.
2.3. Detection of TRAP Using ELF97 and Flow Cytometry.
The endogenous tartrate-resistant acid phosphatase (TRAP)
activity was detected by using the phosphatase substrate
ELF97 (Molecular Probes, Eugene, OR, USA) as described
previously [11], to assess OC differentiation in the presence
of the different concentrations of V4+ or V5+ ions. Cell
fixation was performed after 7 days, using a culture medium
containing 1% paraformaldehyde. After being washed twice
with distilled water, the fixed cells were subsequently incu-
bated with 200𝜇MELF97 in a 110mM acetate buffer staining
solution for a period of 20min. Cells were characterized
for expression of surface markers by using fluorescence-
labeled mouse monoclonal antibodies binding specifically
to human HLA-DR (phycoerythrin (PE) fluorescent labeled;
BectonDickinson Biosciences, San Jose, CA,USA) andCD45
(PerCP fluorescent labeled; Becton Dickinson Biosciences).
To account for the background signal and autofluorescence,
isotype antibodies and unstained controls were used.
A FACS Vantage Cell Sorter with a UV laser was used
for sample analysis. Approximately 105 gated cells were
analyzed. The ELF97 was excited at 350 nm, and the TRAP-
related signal was collected using a 530/30 band pass filter
(515–545 nm).The PE and PerCP fluorochromes were excited
using a 488 nm laser. The signal was collected using a 575/26
and a 675/20 band pass filter. The data was further analyzed
using the Flowjo v8.5.3 software package (Treestar, Ashland,
OR, USA).
2.4. Osteoclast Resorptive Function on the Dentine Slices.
Evidence of OC function and bone resorptive activity was
assessed using lacunar resorption assays on the dentine slices,
as previously described [3]. Whale dentine slices (diameter
15mm, thickness 0.5mm)were cut froma spermwhale tooth,
purchased from Kaempf (Osborne Park, Western Australia,
collected prior to 1972, before the ban on whale hunting in
Australia). Adherent cells (4 × 105 cells/well) were cultured
on dentine slices. The slices were washed with water and left
overnight in a 0.25% ammonium hydroxide solution after a
culturing period of 21 days to remove all cellular material.
Staining was performed with 1% toluidine blue dye in 1%
sodium borate for 10min. A Nikon Inverted Microscope
Eclipse TE 300 (Nikon Instruments, Melville, NY, USA) and
a Nikon CCD digital camera were used for documentation.
The whole surface of the slice was examined. The DXM
1200F-ACT-1 image processing software (Nikon) was used to
analyze the images. A dark-blue excavation on the dentine
surface with a clear rim of unchanged and unstained original
surface located between neighboring pits was defined as
a resorption pit. The extent of resorption was determined
from the number of pits formed and by calculating the total
planar surface area of the resorption pits. The diameter of 30
pits/slice was measured and the mean value used to calculate
the surface of the number of pits counted.The number of pits
was counted using a single blinded observer.
2.5. Calculations and Statistical Analysis. The data was ana-
lyzed using the SPSS for Windows software package (v15.0;
SPSS Inc., Chicago, IL). Independent sample t-tests were con-
ducted to determine whether the mean ion concentrations
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Figure 1: Assessment of cell viability. Cell proliferation (percentage
of basal proliferation) of monocytic cells and osteoclasts under
increasing concentration of vanadium 4+ ions. No differences were
noted in the same concentrations of vanadium 5+ ions (𝑝 > 0.05).
∗𝑝 < 0.001.
were significantly greater than theminimumdetection limits.
A one-way ANOVA test was used to test the differences in
the mean in the expression of the TRAP, as well as differences
in the mean number of resorption pits and the surface area
across the various cell cultures. A 𝑝 value of 𝑝 < 0.05 was
considered to be statistically significant.
3. Results
3.1. Cell Viability. Nontoxic concentrations of V4+ and V5+
ions that did not greatly decrease the MC and OC viability
were defined by MTS colorimetric assays. A significant
reduction in MC and in vitro generated OC was seen
at concentrations of V4+ or V5+ ions greater than 3 𝜇M.
No significant change in MC and OC viability was found
when using concentrations up to 3 𝜇M, indicating the toxic
concentrations for MC and OC (Figure 1). Toxicity of V4+
and V5+ concentrations above 3 𝜇M was additionally con-
firmed by Annexin-5 staining. No significant difference was
found between V4+ and V5+ ions (data not shown) (𝑝 >
0.05). Subsequently, increasing concentrations (0 to 3 𝜇M of
V4+ or V5+) were defined as standard conditions for the
experiments.
3.2. Detection of TRAP Using ELF97 and Flow Cytometry
(FACS). All OC cultures were TRAP-positive while all the
MC cultures supplementedwithOCdifferentiation cytokines
showed a significantly reduced expression of TRAP, indicat-
ing OC differentiation inhibition in the presence of V4+ or
V5+ for all the concentrations (Figure 2). All cultures of MC
exposed only to V4+ or V5+ (no supplementation with OC
differentiation cytokines) showed no expression of TRAP.
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Figure 2: Quantitative analysis of TRAP expression by osteo-
clasts and monocytes supplemented with osteoclast differentiation
cytokines in the presence of increasing concentrations (0 to 3𝜇M)
ofV4+ ions.Mean fluorescence intensity (MFI) indicates the average
TRAP expression per cell. The MFI value indicates relative TRAP
expression when compared with the control (MFI = 121). No
differences were noted between the same concentrations of V4+ and
V5+ ions (𝑝 > 0.05) (∗𝑝 < 0.05).
Quantitative FACS analysis showed that TRAP expression
was significantly decreased in the OC cultures exposed to
increasing concentrations of V4+ or V5+ ions compared with
OC cultured without any V ions (𝑝 < 0.05) (Figure 2).
3.3. Qualitative and Quantitative Assessment of Osteoclastic
Resorptive Function on the Dentine Slices. The resorptive
function was assessed on the dentin slides after the discovery
that V4+ and V5+ ions had an essential effect on OC
differentiation for the selected concentrations.
OC were cultured with and without V4+ or V5+ ions on
dentin slides for a period of 21 days. The extent of lacunar
resorption was analyzed (Figure 3). Between the different
conditions, qualitative and quantitative differences in the pat-
terns of absorption were seen. Compared to the control sam-
ples, exposition to increased V4+ or V5+ ions led to smaller
sized resorption pits, while the resorption pits of untreated
OC were larger. Osteoclasts incubated with the different
concentrations of V4+ or V5+ ions showed a significantly
decreased number of resorption pits and resorption area of
the total dentine surface compared to untreated OC (Fig-
ure 4). Monocytes, as a negative control, showed only very
few resorption pits (22±3.9pits/mm2)with small dentine area
resorption (0.28%, Figure 4). Untreated OC showed an aver-
age of 801 ± 13.2 resorption pits/mm2 with a dentine resorp-
tion area of 10.19% (𝑝 < 0.001). Regarding the resorption
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Figure 3: Assessment of bone resorption. The images show a representative example of resorption pits (dark spots) on dentine slides after 21
days of incubation under different culture conditions. (a) Untreated osteoclasts. (b) Osteoclasts + 4𝜇M vanadium 4+ ions.
area, no difference was detected between V4+ and V5+ ions
(𝑝 > 0.05). Resorption features were not seen on the dentine
slices incubated without cells.
4. Discussion
The hypothesis that V4+ and V5+ ions are able to interfere
with OC differentiation and bone resorptive activity was
clearly supported in this study. The hypothesis was based on
previous data showing the strong effects of different metal
ions on bone metabolism as well as the tendency of V
ions/compounds to accumulate in bone cells [3, 4, 8].
The integrity of the skeleton as well as the osseous
integration of intercortical metal implants (e.g., total joint
arthroplasty) requires the regulated activity of bone-forming
cells (osteoblasts) and bone-resorbing cells (OC). Numerous
growth factors and cytokines with pro- and antiapoptotic
effects are produced in the bone, regulating the balance
between osteoformation and resorption [9, 11, 12]. Thus,
imbalanced bone cell activity results in severe bone alter-
ations and tissue loss leading in the worst cases to implant
loosening without osseointegration. The term “osseointegra-
tion” is defined as incorporation of nonvital components in
a predictive and reliable way into vital bone. This anchorage
mechanism is specifically important if cementless implants
are used [13, 14]. In addition, altered TRAP levels in bone
pathologies like osteoporosis might compromise osseointe-
gration [15].
Metal ions have been shown to affect bone turnover
through a variety of both direct and indirect mechanisms.
It has been already demonstrated that Ti4+ ions act directly
on bone cells by enhancing OC differentiation [3]. In line
with this, Co2+ and Cr3+ ions affected human osteoblasts
by inhibiting the release of alkaline phosphatase, enhancing
apoptosis, RANKL, and osteoprotegerin (OPG) expression,
with enhanced osteoclastogenesis and osteolysis [16, 17]. Fur-
thermore, metal ions induce elevated proinflammatory cyto-
kine secretion such as interleukin- (IL-) 1𝛼/𝛽, IL-6, and tumor
necrosis factor- (TNF-) 𝛼 [4, 18]. TNF-𝛼 has a direct influence
onOC precursors, whereas IL-6 and IL-1𝛼/𝛽 act indirectly by
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Figure 4:Histogram representing themean area (percentage of total
area ± SE) of resorption on dentine slides after 21 days in culture
under different conditions. Note the significant decrease of dentin
resorption by osteoclasts exposed to V4+ ions. No differences were
noted between the same concentrations of V4+ and V5+ ions (𝑝 >
0.05) (∗𝑝 > 0.05).
increasing osteoblast RANKL and M-CSF expression, which
directly drives osteoclastogenesis [4]. Several studies have
reported the bioactivity of vanadate, vanadyl, and different
V4+ complexes on bonemetabolism [19–22]. Low concentra-
tions (<25𝜇M)ofV4+ compounds influence the proliferation
and differentiation of osteoblast-like cells in culture, while
higher concentrations have inhibitory and cytotoxic effects
on osteoblasts. V compounds stimulate the protein tyrosine
phosphorylation through the inhibition of protein tyrosine
phosphatases (PTPases) [23]. The presented results confirm
the cytotoxicity of high concentrations (>3 𝜇M) of V4+ and
V5+ ions on MC and OC in culture. This study demonstrates
the inhibitory action of V4+ and V5+ ions at concentration
< 3 𝜇M on OC differentiation and activity in vitro. This is
based on several observations: (a) significantly decreased
International Journal of Biomaterials 5
expression of TRAP in cultures of MC supplemented with
OCdifferentiation cytokines and exposed toV4+ orV5+ ions,
(b) significantly decreasedTRAPexpression in cell cultures of
mature and functional OC exposed to V4+ or V5+ ions, and
(c) significantly reduced bone resorption by OC exposed to
V4+ or V5+.
5. Conclusion
V-containing implants may reduce OC activity at the bone-
implant interface and thereby decrease bone resorption and
ultimately the rate of implant failure. Primary osseointe-
gration is supported by suppressing local TRAP activity.
Additionally, V complex development with different ligands
might be an alternative strategy of use in skeletal tissue
engineering especially when considering their tendency to
accumulate in bone.
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